Anticoagulant Therapy in Patients Hospitalized With COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anticoagulant Therapy in Patients Hospitalized With COVID-19

Published:2021-12-01 Issue:12 Volume:181 Page:1621
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Wahid Lana¹,Ortel Thomas L.²³

Affiliation:

1. Division of General Internal Medicine, Duke University Medical Center, Durham, North Carolina

2. Division of Hematology, Duke University Medical Center, Durham, North Carolina

3. Department of Medicine, Department of Pathology, Duke University Medical Center, Durham, North Carolina

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2785005/jamainternal_wahid_2021_ic_210027_1638550230.78177.pdf

Reference8 articles.

1. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.;McGonagle;Lancet Rheumatol,2020

2. Incidence of venous thromboembolism in hospitalized patients with COVID-19.;Middeldorp;J Thromb Haemost,2020

3. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial.;Sadeghipour;JAMA,2021

4. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.;Lopes;Lancet,2021

5. Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19.;Lawler;N Engl J Med,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the Efficacy and Safety of Baricitinib Treatment in COVID-19 Patients: a real-world study;2024-05-30

2. The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic;Medicine, Health Care and Philosophy;2023-12-28

3. Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK;eClinicalMedicine;2023-06

4. Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy;Journal of Thrombosis and Haemostasis;2023-04

5. Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland;Frontiers in Cardiovascular Medicine;2023-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3